Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (411-420 of 945) with videos related to

Pageof 95
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1986
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serumA L Barry, R N Jones, R R Packer
Drugs|January 1, 1988
Cefotaxime single-dose surgical prophylaxis in a prepaid group practice. Comparisons with other cephalosporins and ticarcillin/clavulanic acidR N Jones, J M Slepack, W V Wojeski
Diagnostic Microbiology and Infectious Disease|September 1, 1989
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing GroupA L Barry, P C Fuchs, R N Jones
Antimicrobial Agents and Chemotherapy|November 26, 2003
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001J M Bell, J D Turnidge, R N Jones, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging studyR N Jones, K A Gordon, D J Biedenbach
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study GroupM T Lewis, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study GroupD J Biedenbach, D M Johnson, R N Jones
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study GroupD J Biedenbach, D M Johnson, R N Jones
The Journal of Antimicrobial Chemotherapy|January 11, 2001
In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trialR N Jones, R S Hare, F J Sabatelli, et al.
Diagnostic Microbiology and Infectious Disease|July 13, 2001
Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella sppP R Rhomberg, D J Biedenbach, R N Jones
Pageof 95

Showing results (411-420 of 945) with videos related to

Sort By:
Pageof 95
Antimicrobial Agents and Chemotherapy|January 1, 1986
Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serumA L Barry, R N Jones, R R Packer
Drugs|January 1, 1988
Cefotaxime single-dose surgical prophylaxis in a prepaid group practice. Comparisons with other cephalosporins and ticarcillin/clavulanic acidR N Jones, J M Slepack, W V Wojeski
Diagnostic Microbiology and Infectious Disease|September 1, 1989
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing GroupA L Barry, P C Fuchs, R N Jones
Antimicrobial Agents and Chemotherapy|November 26, 2003
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001J M Bell, J D Turnidge, R N Jones, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging studyR N Jones, K A Gordon, D J Biedenbach
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study GroupM T Lewis, D J Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study GroupD J Biedenbach, D M Johnson, R N Jones
Diagnostic Microbiology and Infectious Disease|February 11, 2000
In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study GroupD J Biedenbach, D M Johnson, R N Jones
The Journal of Antimicrobial Chemotherapy|January 11, 2001
In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trialR N Jones, R S Hare, F J Sabatelli, et al.
Diagnostic Microbiology and Infectious Disease|July 13, 2001
Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella sppP R Rhomberg, D J Biedenbach, R N Jones
Pageof 95